Who has invested in HiberCell?

ARCH Venture Partners are named among the investors backing HiberCell.

HiberCell Funding: $250M Raised, Series B (2021)

HiberCell funding overview

HiberCell is based in New York. HiberCell has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in May 2021. The round record for HiberCell runs through 2021; nothing later has been disclosed. Investors on record include ARCH Venture Partners.

HiberCell at a glance

Total raised: $250M
Latest round: Series B
Latest round date: May 2021
Headquarters: New York
Notable investors: ARCH Venture Partners

Frequently asked about HiberCell funding

How much has HiberCell raised?: HiberCell has raised $250M in total disclosed funding across the rounds on record.
Who has invested in HiberCell?: ARCH Venture Partners are named among the investors backing HiberCell.
What was the latest HiberCell funding round?: The most recent disclosed round is a Series B, announced in May 2021.
Where is HiberCell based?: HiberCell is based in New York.
When did HiberCell last raise?: The last disclosed HiberCell round closed in May 2021 at Series B.

We update the HiberCell record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in New York and their backers are listed below.

HiberCell Funding: $250M Raised, Series B (2021)

HiberCell funding overview

HiberCell at a glance

Frequently asked about HiberCell funding

Companies related to HiberCell (36)

Browse related funding lists (5)